A
Aitia
Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
About Aitia
GNS Healthcare is a leading provider of AI-driven precision medicine solutions, focusing on optimizing drug discovery and improving healthcare outcomes. The company operates in the healthcare and pharmaceutical markets, serving clients such as pharmaceutical companies, healthcare providers, and insurance firms. GNS Healthcare leverages advanced machine learning and big data analytics to create predictive models that help in identifying effective treatments and improving patient care. The business model revolves around offering software-as-a-service (SaaS) solutions and consulting services, generating revenue through subscription fees and project-based engagements. By integrating vast amounts of clinical and genomic data, GNS Healthcare enables its clients to make data-driven decisions, ultimately enhancing the efficiency and effectiveness of healthcare delivery.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 143
- Open positions
- None listed
- Dealroom signal
- 61.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Risk Management, Analytics, Biotechnology, Drug Development, Core AI, Spinout, Tech for Biotech and Pharma, AI Applications, DT and LS, science-based
- Business model
- SaaS
News
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Aitia is 20 monthly website visits, down 98.5% over the last three months. Aitia's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Aitia in the Cambridge ecosystem
The Aitia office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Amgen Ventures
Cambia Health Solutions
Mitsui Global Investment
Heritage Provider Network
Amgenbd
Alexandria Equities
Series B and later4 investors entered at this stage
Celgene
Cigna Ventures
Echo Health Ventures
Alexandria Venture Investments
Other known investors1 additional known investor
Cornell University
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aitia on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aitia’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









